F10 and stroke disorder: The Rivaroxaban Once Daily Oral Direct Factor Xa InhibitionCompared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial inAtrial Fibrillation trial introduced rivaroxaban as an anticoagulant for themanagement of NVAF.